Articles with "lamivudine maintains" as a keyword



Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial

Sign Up to like & get
recommendations!
Published in 2018 at "Clinical Infectious Diseases"

DOI: 10.1093/cid/cix1131

Abstract: Clinical Trials Registration NCT02263326. read more here.

Keywords: human immunodeficiency; maintains human; plus lamivudine; immunodeficiency virus ... See more keywords